# Changes in the investigation and management of suspected myocardial infarction and injury during COVID-19: a multi-centre study using routinely collected healthcare data

**Authors:** Lara Chammas, Kevin Yuan, Stephanie Little, Gail Roadknight, Kinga A. Varnai, Shing Chan Chang, Shirley Sze, Jim Davies, Andrew Tsui, Hizni Salih, Ben Glampson, Dimitri Papadimitriou, Abdulrahim Mulla, Kerrie Woods, Kevin O’Gallagher, Anoop D. Shah, Bryan Williams, Folkert W. Asselbergs, Erik Mayer, Richard Lee, Christopher Herbert, Tom Johnson, Stuart Grant, Nick Curzen, Ajay M. Shah, Divaka Perera, Riyaz S. Patel, Keith M. Channon, Amit Kaura, Jamil Mayet, David W. Eyre, Iain Squire, Raj Kharbanda, Andrew Lewis, Rohan S. Wijesurendra

PMC · DOI: 10.3389/fcvm.2024.1406608 · Frontiers in Cardiovascular Medicine · 2024-05-21

## TL;DR

The study found that during the first wave of the COVID-19 pandemic, fewer people were diagnosed with heart attacks, possibly due to changes in hospital visits and clinical practices.

## Contribution

The study reveals how the pandemic affected clinical decision-making and outcomes for patients with suspected heart attacks.

## Key findings

- Fewer patients presented to the hospital during the pandemic, but those who did were more likely to be tested for heart injury.
- There was a significant drop in cardiac procedures and higher mortality rates during the pandemic.
- Positive COVID-19 or heart injury test results were linked to higher mortality, with different risk patterns over time.

## Abstract

The COVID-19 pandemic was associated with a reduction in the incidence of myocardial infarction (MI) diagnosis, in part because patients were less likely to present to hospital. Whether changes in clinical decision making with respect to the investigation and management of patients with suspected MI also contributed to this phenomenon is unknown.

Multicentre retrospective cohort study in three UK centres contributing data to the National Institute for Health Research Health Informatics Collaborative. Patients presenting to the Emergency Department (ED) of these centres between 1st January 2020 and 1st September 2020 were included. Three time epochs within this period were defined based on the course of the first wave of the COVID-19 pandemic: pre-pandemic (epoch 1), lockdown (epoch 2), post-lockdown (epoch 3).

During the study period, 10,670 unique patients attended the ED with chest pain or dyspnoea, of whom 6,928 were admitted. Despite fewer total ED attendances in epoch 2, patient presentations with dyspnoea were increased (p < 0.001), with greater likelihood of troponin testing in both chest pain (p = 0.001) and dyspnoea (p < 0.001). There was a dramatic reduction in elective and emergency cardiac procedures (both p < 0.001), and greater overall mortality of patients (p < 0.001), compared to the pre-pandemic period. Positive COVID-19 and/or troponin test results were associated with increased mortality (p < 0.001), though the temporal risk profile differed.

The first wave of the COVID-19 pandemic was associated with significant changes not just in presentation, but also the investigation, management, and outcomes of patients presenting with suspected myocardial injury or MI.

## Linked entities

- **Diseases:** myocardial infarction (MONDO:0005068), COVID-19 (MONDO:0100096)

## Full-text entities

- **Diseases:** MI (MESH:D009203), chest pain (MESH:D002637), myocardial injury (MESH:D009202), COVID-19 (MESH:D000086382)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11148217/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11148217/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC11148217/full.md

---
Source: https://tomesphere.com/paper/PMC11148217